Objective. Myositis is associated with muscletargeted inflammation and is observed in some Treg cell-deficient mouse models. Because an autoimmune pathogenesis has been strongly implicated, the aim of this study was to investigate the hypothesis that abnormal exposure to muscle antigens, as observed in muscle injury, can induce autoimmune-mediated myositis in susceptible hosts. 
Idiopathic inflammatory myopathies are a group of systemic autoimmune diseases characterized by chronic muscle inflammation resulting in weakness (1) and a variety of clinical manifestations (2) . Because inflammation of muscle tissue is the underlying mechanism of disease pathology in each condition, current treatments include broad-spectrum immunosuppressive agents and, more recently, targeted immune therapy directed against inflammatory cells and inflammatory mediators (3, 4) . Although these treatments can be relatively effective, they can result in significant complications due to systemic immunologic suppression (5) (6) (7) . However, the development of more specific therapies for immune-mediated myositis requires more data regarding pathogenesis (8) . Animal models can provide insight into the pathogenesis of these diseases and facilitate the identification of new pathways that can be targeted therapeutically.
Synaptotagmin VII (Syt VII) is a member of the synaptotagmin family of membrane-trafficking proteins (9) . Mice that have mutations affecting both copies of the Syt VII allele develop an inflammatory myositis, presumably as a consequence of exposure to endogenous muscle tissue antigen through impaired membrane resealing (10) . Thus, it has been proposed that Syt VII deficiency can cause inflammation by activation and expansion of lymphocytes through exposure to endogenous antigens not normally encountered during the initial establishment of immune tolerance (11) . The FoxP3 gene product scurfin is an X-linked transcription factor involved in the maturation and activation of Treg cells (12) . Treg cells actively suppress autoreactive cells and control the immune response (13) . In humans, immune dysregulation, polyendocrinopathy, and enteropathy, X-linked syndrome is caused by a FoxP3 mutation that leads to a severe multiorgan autoinflammatory condition frequently resulting in death within the first 2 years of life (14) . Scurfy (FoxP3 mutant) mice devoid of functional Treg cells also succumb to multiorgan inflammation primarily affecting the skin, lungs, and liver (12) . We previously demonstrated that intraperitoneal adoptive transfer of scurfy mouse lymph node cells into recombination-activating gene 1 (RAG-1)-null mice not only recapitulated these manifestations but also induced inflammation in the colon, salivary glands, and lacrimal glands (15) . Hence, although scurfy mice display autoimmune responses against only a few target organs, transfer of scurfy mouse lymphocytes to RAG-1-null mice induces severe inflammation in some of the organs that were spared in the de novo inflammatory response (16) . This reveals the presence of a repertoire of autoreactive immune cells against more organs than initially observed in the scurfy mouse.
In both scurfy mice and RAG-1-null mice that underwent adoptive transfer, muscle tissue was spared from an inflammatory response. To examine the role of antigens to muscle tissue in this phenomenon, we administered intramuscular injections of scurfy mouse lymph node cells into RAG-1-null recipients, thus inflicting a muscle injury and inducing severe myopathy (16) . We hypothesized that despite a complete deficiency of Treg cells, scurfy mice and the RAG-1-null recipients of scurfy mouse cells still fail to develop muscle inflammation due to a lack of critical exposure to muscle antigens.
In the present study, we tested this hypothesis by comparing FoxP3/Syt VII double-mutant mice with Syt VII mutant mice to determine the influence of Treg cells on suppression of muscle inflammation. 
mice.
Genotyping. The tails of all mice in litters with FoxP3 or Syt VII mutations were clipped at 22 (Ϯ2) days of age. DNA was extracted according to a published protocol (The Jackson Laboratory) using a DNeasy Blood & Tissue Kit (Qiagen) according to the manufacturer's instructions. Polymerase chain reaction (PCR) amplification was performed for both genes, using The Jackson Laboratory protocol. The primer sequences used for amplification were as follows: for WT Syt VII, forward 5Ј-CATCCTCCACTGGCCATGAATG-3Ј and reverse 5Ј-G-CTTCACCTTGGTCTCCAG-3Ј; for mutant Syt VII, forward 5Ј-CTTGGGTGGAGAGGCTATTC-3Ј and reverse 5Ј-AGG-TGAGATGACAGGAGATC-3Ј; for WT FoxP3, forward 5Ј-CTCAGGCCTCAATGGACAAG-3Ј; for mutant FoxP3, forward 5Ј-TCAGGCCTCAATGGACAAAA-3Ј. A common reverse primer (5Ј-CATCGGATAAGGGTGGCATA-3Ј) was used for FoxP3. The PCR products were electrophoresed on 2% agarose gels, and the bands were visualized with ethidium bromide. 28 . All mice were killed by cervical dislocation, under anesthesia. The quadriceps femoris muscle from each mouse was resected and flash-frozen in liquid nitrogen-cooled isopentane followed by cryosectioning, or was fixed immediately by immersion in neutral buffered 10% formalin and then processed into paraffin. Serial paraffin sections were stained with hematoxylin and eosin (H&E) (Leica Microsystems) or labeled by indirect immunohistochemistry to detect CD3 (Dako), B220 (CD45R; BD Biosciences), and F4/80 (AbD Serotec). Serial frozen sections were used for H&E staining and indirect immunohistochemistry to localize CD4 and CD8 (both from BD Biosciences). All staining was performed on tissue sections cut at 4 m, according to the manufacturer's protocol.
Microscope slide imaging and analysis. Glass slides were scanned at 200ϫ or 400ϫ resolution on an Aperio ScanScope XT eSlide capture device and analyzed using Aperio ImageScope digital analysis version 9.1 software. To quantify the extent of inflammation and lymphocyte localization, an Aperio positive pixel count algorithm was run to determine cellular nuclei or positively labeled membranes using calibrated hue, saturation, and intensity values following previously described methods of computer-assisted image analysis (17) . From each mouse, 10 measurements of identical total surface area of muscle tissue were quantitated to define a mean value of strong positive pixel intensity. All digitization was verified by manual slide analysis and histopathologic scoring, as described below.
Histopathologic scoring. H&E-stained paraffin sections of skeletal muscle were submitted for independent histopathologic analysis by a board-certified veterinary pathologist (BB). Microscopic lesions in the muscle indicating degeneration and inflammation were subjected to blinded histopathologic analysis using the 10ϫ objective of a bright-field light microscope and a tiered, semiquantitative scoring scheme with predefined criteria (0 ϭ within normal limits, 1 ϭ minimal change, 2 ϭ mild change, 3 ϭ moderate change, and 4 ϭ marked change).
Statistical analysis. All data were expressed as the mean Ϯ SD. Statistical significance was determined by Student's paired 2-tailed t-tests using Microsoft Excel version 2010 software. P values less than or equal to 0.05 were considered significant.
RESULTS

Effect of Syt VII deficiency in mice without Treg cells. Syt VII deficiency results in membrane leakage
and is reported to induce spontaneous myositis (11) , but the extent of inflammation is limited compared with that observed in our scurfy mouse lymphocyte adoptive transfer model (16) . To investigate the role of Treg cells in the suppression of spontaneous myositis, we introduced Treg cell deficiency onto the Syt VII mutant background by generating FoxP3/Syt VII double-mutant mice, in order to examine the combined effects of these 2 mutations on the development of myositis.
In muscle tissue from mice with the Syt VII deficiency alone (Syt VII Ϫ/Ϫ ), the leukocyte infiltrate was mild but diffuse and was observed in both necrotic and non-necrotic areas. This inflammation was evident at 4 weeks but decreased slightly at later time points ( Figure 1A) . No distinguishable histologic difference was observed between Syt VII ϩ/ϩ and Syt VII ϩ/Ϫ geno-types at any time point (data not shown). Histopathologic scores for muscle inflammation in Syt VII Ϫ/Ϫ mice were statistically significantly higher than those in Syt ) mouse lymph node cells into RAG-1-null recipients via either intraperitoneal or intravenous injection was unable to induce inflammation of skeletal muscle, while intramuscular injection of scurfy mouse cells did trigger myositis (16) . Adoptive transfer of lymph node preparations from male scurfy mice with and those without Syt VII deficiency were delivered via intraperitoneal injection into RAG-1-null mice to determine whether the priming of lymph node cells in the double-mutant mice, in which myositis develops spontaneously, imparts the ability of these cells to induce inflammation despite the absence of muscle injury or Syt VII mutation in the recipient. Adoptive transfer of FoxP3 Immunohistochemical analysis further revealed that the response included both CD4ϩ and CD8ϩ T cells and F4/80ϩ macrophages, while B cells were again absent in the inflammatory infiltrate ( Figure 3C ). Additionally, staining for interleukin 17 (IL-17)-secreting cells revealed little or no positive detection (data not shown). Digital image analysis demonstrated that CD4ϩ T cells were detected at significantly higher levels relative to the other cell types in the muscle tissue infiltrates ( Figure 3D ). These data demonstrated that leukocytes educated in the FoxP3/Syt VII doublemutant mouse are sufficient to cause severe myositis in an adoptive transfer model.
Role of lymph node cell priming with abnormal muscle antigens in the induction of myositis in the RAG-1-null mouse adoptive transfer model. In order to further explore the postulate that endogenous antigen exposure leads to myositis development, adoptive transfer of Treg cell-deficient (FoxP3 Ϫ/Y ) mouse lymph node cells into RAG-1-null mice was performed under several conditions that aberrantly exposed these cells to muscle antigens. Because muscle tissue homogenate (18) (19) (20) (21) (22) and myosin protein (23) have been previously 
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shown to induce muscle-specific inflammatory responses when coadministered with immunoadjuvant, FoxP3 mutant mouse lymph node cells were injected intraperitoneally into RAG-1-null mice in conjunction with muscle tissue homogenate or purified myosin protein. This resulted in pronounced myositis, and the resulting inflammation was similar to that observed when intramuscular injection was used as a positive control ( Figure  4A ). Quantitation (using digital image analysis) of the inflammatory response induced by intramuscular injection showed significant infiltration compared with that induced by intraperitoneal injection ( Figure 4B ). In addition, the mean Ϯ SD histopathologic score resulting from intramuscular injection was 3.0 Ϯ 0.0, compared with scores of 3.4 Ϯ 0.55 and 2.6 Ϯ 0.55 resulting from intraperitoneal coinjection with muscle tissue homogenate and intraperitoneal coinjection with purified myosin protein, respectively ( Figure 4C ). All of these scores were significantly higher than the score for intraperitoneal adoptive transfer of FoxP3-deficient mouse lymph node cells alone (0.9 Ϯ 0.57) ( Figure 4C ). To characterize the cell subtypes present in these muscle tissue infiltrates, immunohistochemistry was performed on sections obtained from RAG-1-null mice following these adoptive transfers. As with transfer of FoxP3 Ϫ/Y /Syt VII Ϫ/Ϫ mouse lymph node cells, concurrent introduction of FoxP3 Ϫ/Y mouse lymph node cells plus muscle protein resulted in inflammatory responses consisting largely of T cells with a few macrophages, while B cells were absent. Specifically, the infiltrates were composed primarily of CD4ϩ T cells, with CD8ϩ T cells and F4/80ϩ macrophages present to a lesser extent ( Figure 5A ). Digital image analysis showed that CD4ϩ T cells were present at significantly higher levels than CD8ϩ T cells, macrophages, or B cells ( Figure 5B either additional lymph node cells or purified Treg cells from WT B6 mice. Treg cell supplementation suppressed muscle inflammation in RAG-1-null mice that received intramuscular injections of FoxP3-deficient mouse lymph node cells ( Figure 6A ) and in RAG-1-null mice that received intraperitoneal injections of lymph node cells from FoxP3/Syt VII double-mutant mice ( Figure 6B ). The extent of inflammation was reduced significantly by the addition of Treg cells, as assessed both quantitatively by digital image analysis and semiquantitatively by coded histopathologic scoring (from a mean Ϯ SD of 3.0 Ϯ 0.0 without Treg cell supplementation to 0.9 Ϯ 0.57 with Treg cell supplementation) ( Figure 6C ). These results demonstrate the extensive Treg cell repertoire of WT mice and the ability of these cells to modulate the immune response in this model of myositis.
DISCUSSION
Because an autoimmune pathogenesis of myositis has been strongly implicated, this remains the focus of both standardized and emerging therapeutic strategies (24) . Recent work has also shown that patients with dermatomyositis (DM) have decreased numbers of Treg cells in both peripheral blood and skin lesions when compared with healthy subjects (25) . Furthermore, FoxP3ϩ Treg cells have been identified at the sites of muscle inflammation in humans, and the association of Treg cells with myoreactive Teff cells has also been demonstrated (26) . To our knowledge, the present study is the first to investigate the contribution of abnormal muscle antigen availability to the pathogenesis of myositis in a Treg cell-deficient environment.
FoxP3-deficient mice display intense autoimmune inflammatory processes involving multiple organs but exhibit very little evidence of myositis (16) . In contrast, Syt VII mutant mice develop a mild, selflimiting inflammatory response involving the muscles (11). Here, it is possible that muscle antigen-specific Treg cells develop, which at later stages effectively resolve the inflammation. Our findings show that the deficiency of both genes resulted in the development of significant muscle tissue inflammation, which can be attributable to the lack of Treg cell suppression in the presence of abnormal muscle antigen availability. The robust myositis induced by intraperitoneal adoptive transfer of lymph node cells from FoxP3/Syt VII doublemutant mice into RAG-1-null mice demonstrates that the Syt VII deficit is necessary for the generation and expansion of effector immune cells that can target muscle but is not required in the affected organ.
Antigens from muscle tissue have been shown to elicit an inflammatory response when given in conjunction with adjuvant stimulation (18) (19) (20) (21) (22) (23) . Because immunoadjuvant injections in animal models can elicit welldefined mechanisms of inflammation, even when given alone, and have also been shown to lead to aspecific immune cell activation (27) , we examined the role of intracellular muscle proteins as a means of promoting myositis in our Treg cell-deficient model. Given the strong association of Treg cells with myositis (26), the conclusions supported by our data may therefore ultimately hold more physiologic relevance and therapeutic potential than conclusions based on data derived from adjuvant-based models. Transfer of Treg cell-deficient lymph node cells into RAG-1-null mice by intraperitoneal injection with either muscle tissue homogenate or purified myosin protein caused significant muscle inflammation. Although the greatest inflammatory responses were observed with coadministration of muscle tissue homogenate, myosin protein by itself stimulated notable muscle tissue inflammation. Considering that anti-myosin autoantibodies have been previously detected in patients with DM (28) , this indicates that myosin is at least one antigen capable of generating myositis. Therefore, the neutralization of extracellular myosin represents a potential therapeutic target for minimizing autoinflammation.
Coadministration of lymph node cells from FoxP3 Ϫ/Y mice with muscle tissue homogenate resulted in an enhanced inflammatory response compared with coadministration with myosin protein, which implies that additional intracellular autoantigens are presumably functioning pathogenically as well. Consistent with these data, Hsp60 in inflamed muscle tissue has been shown to be the target of regulatory autoreactive T cells in patients with juvenile DM (29) , and histidyl-transfer RNA synthetase has been shown to be a target of human ␥/␦ T cell receptor in the lesions of patients with polymyositis (30, 31) . Another muscle-specific protein, chromatin remodeler Mi-2, is involved in muscle regeneration and has also been identified as a potential autoantigen (32) . Furthermore, autoantibodies to acetylcholine receptor and muscle-specific kinase have been observed in patients with myasthenia gravis (33) . Taken together, these findings suggest that antigen-specific immunotherapy may require an individualized patient approach despite similar histologic and clinical presentations.
In the present study, the muscle inflammatory infiltrate was devoid of B cells but included macrophages and a significant number of T cells in all cases. This pattern is consistent with prior mouse models of myositis, in which inflammatory infiltrates consisted predominantly of T cells (chiefly CD4ϩ cells with some CD8ϩ cells) and occasional macrophages, but no B cells (34) . In addition, dendritic cells and IL-17-secreting cells were either present in insignificant numbers or were absent from the muscle tissue infiltrates in all experimental conditions. This is consistent with our previous studies in the scurfy mouse model, which demonstrated that the majority of the tissue-infiltrating cells are CD4ϩ Th1 or Th2 cells (35, 36) .
In samples obtained from patients with juvenile DM, inflamed muscle tissue was shown to contain autoreactive T cells that significantly proliferate when exposed to self antigen (29) . Furthermore, our model has shown that adoptive transfer of CD4ϩ cells alone is sufficient to recapitulate muscle tissue pathology (16) . In addition, we recently showed that CD4ϩ T cells from Treg cell-deficient mice highly express several receptors involved in the trafficking of T cells to the sites of inflammation (35, 36) , indicating that injury or stress to muscle tissue may result in up-regulation of ligands to these trafficking receptors and therefore play an important role in the recruitment of muscle antigen-primed T cells to muscle. Given that the pathogenesis of myositis most likely derives from T cells stimulated by self antigens to induce autoimmunity (37) , and that a subset of CD4ϩ and CD8ϩ T cells can be detected in muscle tissue despite immunosuppressive therapy (38), we conclude that effector T cells are essential in both the development of and the sustained inflammation involved in disease pathology.
With Treg cell supplementation at a 1:10 ratio, minimal muscle tissue infiltrate was observed. Similarly, the suppressive role of polyclonal Treg cells expanded in vitro in mediating experimental autoimmune myositis was recently demonstrated in a reproducible mouse model (34) . Because there are no definitive data to date demonstrating the involvement of Treg cells in human myositis, our results underscore the need for such investigations. Recent studies in type 1 diabetes mellitus demonstrated that patients with normal levels of circulating Treg cells have a Treg cell defect locally in the pancreas and lymph nodes (39) ; this suggests that Treg cells in the muscles should be analyzed more closely to better understand myositis pathology. Additionally, the therapeutic application of Treg cells was shown to resolve already-established inflammatory disease in mouse models of acute renal (40) and lung injury (41) . Furthermore, it has been suggested that Treg cells contribute to healing in addition to immunosuppression (42) . Considering the translational research being pursued in the use of Treg cell immunotherapy to treat Crohn's disease (43) and graft-versus-host disease (44), our results suggest that Treg cells may also be of critical importance when exploring future therapeutic avenues for treating autoimmune-mediated myositis.
Mechanical stress and drug-induced injury to muscle cells may lead to reversible cell degeneration or myofiber death, both of which may allow the abnormal release of endogenous muscle antigens that potentially can invoke an autoimmune myopathy. Importantly, under normal physiologic conditions, these damaged muscle cells should be rapidly cleared by the tissue-resident and circulating macrophages in order to avoid an autoimmune response. Natural Treg cells specific for endogenous antigens should also be present or induced from naive T cells to suppress this potential inflammatory response. Dysregulation of this system could then result in an autoimmune response. Accordingly, our in vivo mouse system will be valuable in studying the myopathy associated with drug-induced injury, particularly because in some cases the spectrum of myopathy following a muscle injury involves an immune mechanism that is responsive to steroid treatment (45) . Furthermore, this model could be used to demonstrate that specific nonimmune injury to a particular organ may be the means by which systemic autoimmune diseases can target a specific organ. Taken together, these data demonstrate 3268 YOUNG ET AL interplay between aberrant antigen exposure, Treg cell deficiency, and autoimmunity.
